Terminalia chebula Extract Acts as a Potential NF‐κB Inhibitor in Human Lymphoblastic T Cells
- 20 April 2011
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 25 (6) , 927-934
Abstract
Terminalia chebula (TC) is native to southern Asia to southwestern China and is used in traditional medicine for the treatment of human ailments including malignant tumors and diabetes. This plant also has antibacterial and immunomodulatory properties. Nuclear factor kappa-light chain-enhancer of activated B cells (NF-κB) is responsible for the expression of numerous genes involved in cell survival, proliferation, angiogenesis, inflammation, invasion and metastasis, among other processes. This study aims to assess the NF-κB inhibitory effect of TC extract in human lymphoblastic T (Jurkat) cells. The effects of TC extract were investigated using the FRET-based Gene Blazer technique in transfected Jurkat-NF-κB-RE-bla cells. The concentration of TC extract required for NF-κB inhibition was determined by a cell proliferation assay. Treatment with TC extract (50 μg/mL) inhibited NF-κB activity and protected against IκBα degradation and strongly suppressed IκBα phosphorylation in Jurkat-NF-κB-RE-bla cells. This treatment might be crucial for inhibiting NF-κB translocation and activation. In addition, the TC extract downregulated certain NF-κB regulated genes, including IL-8 and MCP-1, in Jurkat-NF-κB-RE-bla cells. Moreover, gallic acid was identified from the TC extract demonstrating its ability to inhibit NF-κB activity in Jurkat-NF-κB-RE-bla cells. Further studies to identify the role of gallic acid in NF-κB inhibition may uncover the crucial antiinflammatory and antitumor properties of the TC extract. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
Funding Information
- Basic Research Program of the Korea Science and Engineering Foundation (KOSEF-2009-0077023)
This publication has 42 references indexed in Scilit:
- NFκB: a promising target for natural products in cancer chemopreventionPhytotherapy Research, 2010
- The Role of NF-κB and H3K27me3 Demethylase, Jmjd3, on the Anthrax Lethal Toxin Tolerance of RAW 264.7 CellsPLOS ONE, 2010
- NFκB1/p50 Is Not Required for Tumor Necrosis Factor-Stimulated Growth of Primary Mammary Epithelial Cells: Implications for NFκB2/p52 and RelBEndocrinology, 2007
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- Antioxidant activity of gallic acid from rose flowers in senescence accelerated miceLife Sciences, 2005
- T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytesCurrent Opinion in Immunology, 2004
- To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosisOncogene, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Cytokine-Induced Stabilization of Newly Synthesized IκB-αBiochemical and Biophysical Research Communications, 2001
- Hydrolysable tannins and related compound having cytotoxic activity from the fruits ofTerminalia chebulaArchives of Pharmacal Research, 1995